BVSBioventus Inc.
Surgical & Medical Instruments & Apparatus
- Revenue
- $568M
- 0.9% YoY
- Operating margin
- 9.5%
- 458% YoY
- EBITDA
- $101M
- 194% YoY
- Market cap
- —
- Employees
- —
- Net debt / EBITDA
- 3.3×
- $328M net debt
- AI in 10-K
- —
Red flags 0 of 9
- TSR below peersClear—3+ of last 5 years
- High CEO pay despite TSRClear—Median CEO pay ≥ $15M and TSR flag
- Active 13DClear0 filingsActive-intent 13D in 18 months
- Net insider sellingClear$0 netNet sales over $10M in 12 months
- Earnings not backed by cashClear328% of net incomeCash flow under 80% of net income
- Dilutive SBCClear2% of revenueOver 10% of revenue
- Payouts exceed cash flowClear0% of cash flowBuybacks + dividends over cash flow
- Goodwill-heavyClear1% of assetsOver 40% of assets
- Shareholder dissentClear—Any vote under 80% support
Financials
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | YoY |
|---|---|---|---|---|---|---|
| Revenue | $431M | $512M | $512M | $573M | $568M | 0.9% |
| Operating income | $12M | −$167M | −$82M | −$15M | $54M | 455% |
| Net income | $19M | −$159M | −$156M | −$36M | $23M | 163% |
| Operating cash flow | $23M | −$14M | $15M | $39M | $75M | 92% |
| Capex | $14M | $1M | $7M | $1M | $3M | 155% |
| Stock-based comp | $20M | $18M | $3M | $13M | $13M | 4.5% |
Deal filings
None.
13D filers
None on file.
Insider trading
No open-market trades in the last 12 months.
Pay vs performance
No pay-versus-performance disclosure yet.